Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

關於 Lite Strategy

成立時間2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
社群
Twitter
Website
標簽
Publicly listed company
Crypto Stocks

熱度值變化趨勢

暫無數據

團隊成員

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

投融資詳情

Post-IPO(2025-07-21)
金額$31.65億
估值--